Production of biological active murine IFN-γ by recombinant Lactococcus lactis

FEMS Microbiology Letters

Volumn 280, Issue 2, 2008, Pages 144-149

  Bermúdez Humarán, Luis G ^a,c   Cortes Perez, Naima G ^b,c   L'Haridon, René ^b   Langella, Philippe ^c  

^a CEMAGREF   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c Laboratoire d'Ecologie et de Physiologie du Système Digestif   (France)

Author keywords

Cytokines; IFN ; Lactic acid bacteria; Lactococcus lactis; Live vector

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETIC ENGINEERING; GRAM POSITIVE BACTERIUM; INTERFERON PRODUCTION; LACTIC ACID BACTERIUM; LACTOCOCCUS LACTIS; MOLECULAR CLONING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS;

BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; MURINAE; POSIBACTERIA; VESICULAR STOMATITIS VIRUS;

EID: 39649104301     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2007.01038.x     Document Type: Article

References (24)

1. Archer F, Bachelin C, Andreoletti O et al 2004) Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol 78: 482 490.
2. Bermúdez-Humarán LG, Langella P, Miyoshi A, Gruss A, Guerra RT, Montes de Oca-Luna R Le Loir Y (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68: 917 922.
3. Bermúdez-Humarán LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R Le Loir Y (2003) Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 71: 1887 1896.
4. Bermúdez-Humarán LG, Corthier G Langella P (2004) Recent advances in the use of Lactococcus lactis as live recombinant vector for the development of new safe mucosal vaccines. Recent Res Dev Microbiol 8: 147 160.
5. Bermúdez-Humarán LG, Cortes-Perez NG, Lefevre F et al 2005) A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 175: 7297 7302.
6. Boehm U, Klamp T, Groot M Howard JC (1997) Cellular responses to interferon-γ. Annu Rev Immunol 15: 749 795.
7. Buccato S, Maione D, Rinaudo CD, Volpini G, Taddei AR, Rosini R, Telford JL, Grandi G Margarit I (2006) Use of Lactococcus lactis expressing pili from group b Streptococcus as a broad-coverage vaccine against streptococcal disease. J Infect Dis 194: 331 340.
8. Byrd CM, Bolken TC, Jones KF, Warren TK, Vella AT, McDonald J, King D, Blackwood Z Hruby DES (2002) Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine 22: 2197 2205.
9. Cortes-Perez NG, Poquet I, Oliveira M, Gratadoux JJ, Madsen SM, Miyoshi A, Corthier G, Azevedo V, Langella P Bermúdez-Humarán LG (2006) Construction and characterization of a Lactococcus lactis strain deficient in intracellular ClpP and extracellular HtrA proteases. Microbiology 152: 2611 2618.
10. Cortes-Perez NG, Ah-Leung S, Bermudez-Humaran LG, Corthier G, Wal JM, Langella P Adel-Patient K (2007) Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin Vaccine Immunol 14: 226 233.
11. Frees D Ingmer H (1999) ClpP participates in the degradation of misfolded protein in Lactococcus lactis. Mol Microbiol 31: 79 87.
12. Hanniffy SB, Carter AT, Hitchin E Wells JM (2007) Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195: 185 193.
13. Kuipers O P, de Ruyter PG, Kleerebezen M de Vos WM (1998) Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64: 15 21.
14. Langella P, Le Loir Y, Ehrlich SD Gruss A (1993) Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp lactis. J Bacteriol 175: 5806 5813.
15. Poquet I, Saint V, Seznec E, Simoes N, Bolotin A Gruss A (2000) HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol 35: 1042 1051.
16. Rabhi-Essafi I, Sadok A, Khalaf N Fathallah DM (2007) A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng Des Sel 20: 201 209.
17. Rubinstein S, Familletti PC Pestka S (1981) Convenient assay for interferons. J Virol 37: 755 758.
18. Sambrook J, Fritsch EF Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Schotte L, Steidler L, Vandekerckhove J Remaut E (2000) Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb Technol 27: 761 765.
20. Steidler L Rottiers P (2006) Therapeutic drug delivery by genetically modified Lactococcus lactis. Ann N Y Acad Sci 1072: 176 186.
21. Steidler L, Wells JM, Raeymaekers A, Vandekerckhove J, Fiers W Remaut E (1995) Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol 61: 1627 1629.
22. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352 1355.
23. van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM Simons G (1990) Cloning, expression in Escherichia coli and characterization of usp45, a gene encoding a highly secreted protein from Lactococcus lactis MG1363. Gene 95: 155 160.
24. Wu C, Yang G, Bermúdez-Humarán LG, Pang Q, Zeng Y, Wang J Gao X (2006) Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Int Immunopharmacol 6: 610 615.